EluNIR Ridaforolimus Eluting Coronary Stent System LUN400R33USRecalls & reported problems
Medinol Ltd. · Class 3 · Implant
All models of EluNIR Ridaforolimus Eluting Coronary Stent System (27)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290107013963), received between May 16, 2018 and May 16, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Difficult to Remove1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 16, 2018Difficult to Remove; Difficult to Remove
A CASE WAS REPORTED IN WHICH THE SPRING TIP STRETCHED OUT WHILE TAKING OUT THE BALLOON, AFTER A 4.0 X 33 DEPLOYMENT. THERE WAS NO PATIENT INJURY. ADDITIONAL INFORMATION RECEIVED ON FEBRUARY 27, 2018: THE TARGET LESION WAS IN THE MID RIGHT CORONARY ARTERY (RCA), THE LESION WAS TIGHT AND SEVERELY TORTUOUS, CALCIFICATION UNKNOWN. THE PRODUCT WAS STORED PROPERLY ACCORDING TO THE IFU. NO DAMAGE TO THE PRODUCT PACKAGING WAS NOTED UPON INSPECTION PRIOR TO USE. NO DIFFICULTY WAS REPORTED REMOVING THE PRODUCT FROM THE PACKAGING. THE DEVICE WAS PREPPED ACCORDING TO IFU. NO ANOMALY WAS NOTED DURING OR AFTER THE DEVICE WAS PREPPED. THE PRODUCT, OR ANY OF THE OTHER DEVICES USED WITH IT, HAD NOT BEEN RE-STERILIZED. THE GUIDEWIRE PORT WAS FLUSHED AS OUTLINED IN THE IFU PRIOR TO LOADING ON THE GUIDEWIRE. SIZE SHEATH USED WAS 6 AND GUIDE WIRE 0.014. PRIOR TO INSERTING THE STENT DELIVERY SYSTEM (SDS) IN THE CATHETER, THE BALLOON WAS NOT INFLATED OR PARTIALLY INFLATED. NEGATIVE PRESSURE WAS APPLIED TO THE SDS. THE BALLOON WAS STICKING AND DIFFICULT TO REMOVE FROM THE PATIENT, IT TOOK A COUPLE OF ATTEMPTS. WHEN THE SPRING WAS COMING OUT OF THE SHEATH, THE PHYSICIAN NOTICED THAT SOMETHING SEEMED WRONG,
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7517499 ↗
Other Coronary Drug-Eluting Stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page